Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 4Withdrawn 1Suspended 1

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 376Polycystic Ovary Syndrome 41Neoplasm Metastasis 23Endometrial Neoplasms 22Ovarian Neoplasms 16Neoplasms 14Infertility 12Advanced Breast Cancer 10Fallopian Tube Neoplasms 8Carcinoma, Intraductal, Noninfiltrating 8Triple Negative Breast Neoplasms 7Recurrence 7Osteoporosis 7Carcinoma, Ductal, Breast 7Breast Neoplasms, Male 7Breast Diseases 7Carcinoma, Lobular 6Breast Carcinoma In Situ 6Prostatic Neoplasms 5Leiomyoma 4Infertility, Female 4Hereditary Sensory and Autonomic Neuropathies 4Breast Cancer Metastatic 4Arthralgia 4Obesity 3Neoplasms, Hormone-Dependent 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Anovulation 3Uterine Neoplasms 2

Interventions

Tamoxifen 21Radiotherapy 9Chemotherapy, Adjuvant 9Specimen Handling 8Early Intervention, Educational 8Anastrozole 7Neoadjuvant Therapy 6Methods 6Letrozole 6Psychiatric Rehabilitation 5Practice Guidelines as Topic 5Immunohistochemistry 5Counseling 5Biopsy 5Standard of Care 4Mastectomy, Segmental 4Mass Spectrometry 4Magnetic Resonance Spectroscopy 4Gene Expression Profiling 4Educational Status 4Behavior Therapy 4exemestane 3Radiation Dose Hypofractionation 3Radiation 3Brachytherapy 3Watchful Waiting 2Therapeutics 2Telemedicine 2Taxes 2Surveys and Questionnaires 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Breast Carcinoma In Situ × Letrozole × Clear all
NCT06671912 2026-06-02

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended
1,156 enrolled
Breast

Breast Carcinoma In Situ

NCT00290745 2020-12-04

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

University of California, San Francisco

Phase 1/2 Completed
79 enrolled 15 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Fred Hutchinson Cancer Center

Phase 4 Withdrawn
Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT00090857 2018-03-30

WISE

Dana-Farber Cancer Institute

Phase 2 Completed
49 enrolled 17 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00004205 2017-12-12

BIG 1-98

ETOP IBCSG Partners Foundation

Phase 3 Completed
8,028 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01077453 2014-10-20

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

National Cancer Institute (NCI)

Phase 1 Completed
112 enrolled
Breast

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon âš¡